Jan 1, 2025 · The FDA granted full approval to erdafitinib (Balversa) for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma with susceptible FGFR3 genetic alterations whose disease has progressed on or after at least 1 line of prior systemic therapy, according to the FDA.The treatment is not recommended for patients who have not received …

Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.

Feb 3, 2025 · Today, hundreds of future urologists received results from the 2025 Urology Residency Match—the process through which medical students and other applicants are connected with the program at which they will complete their residency. 1

Oct 7, 2019 · Uncomplicated urinary tract infection is one of the most common indications for antimicrobial exposure in otherwise healthy women. In the past 20 years, antimicrobial resistance among uropathogens has increased dramatically.

Sep 26, 2024 · Findings from the pooled analysis were published in European Urology. 1 “Our findings give patients and doctors valuable insights into what to expect after ADT treatment, helping them make informed decisions about managing side effects and improving long-term outcomes," said senior author Amar U. Kishan, MD, in a news release on the findings. 2 …

Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.

Dec 28, 2024 · In this video, Helen Y. Hougen, MD, shares the background and findings from the study, “Adding a Coefficient for Race to the 4Kscore Improves Calibration for Black Men.” Watch the video here. Dr. Murphy on increasing diversity in cancer clinical trials. In this podcast episode, Adam B. Murphy, MD, MBA, MSCI, discusses the need to increase diversity in clinical trials, …

Sep 10, 2021 · At the 2021 American Urological Association annual meeting, Dean Elterman, MD, MSc, FRCSC, presented the studies “Rezūm water vapor therapy for large volume (≥80 mL) benign prostatic enlargement: large, multi-center cohort,” 1 and “Pooled analysis of bladder function post-Aquablation.” 2 In these studies, the Rezum water vapor and Aquablation benign …

Jun 15, 2015 · A two-drug treatment regimen works better than monotherapy for incontinent overactive bladder patients, researchers reported at the AUA annual meeting in New Orleans.. Related - PTNS for overactive bladder: Patient selection and technique The beta-3 adrenergic agonist mirabegron (Myrbetriq) used as add-on therapy with the antimuscarinic drug …

Sep 12, 2018 · Dr. Parsons is professor of urology, division of urologic oncology, department of urology, Moores UCSD Comprehensive Cancer Center, La Jolla, CA.. Patients have become voracious consumers of the medical literature. Each week, a flurry of new urology studies surface in the popular media to feed public interest.